Deltex Medical Group plc

DTXMF · OTC
Analyze with AI
12/31/2024
6/30/2024
12/31/2023
6/30/2023
Operating Activities
Net Income-$1,251-$546-$719-$538
Dep. & Amort.$116$123$75$58
Deferred Tax$0$0-$557$37
Stock-Based Comp.$15$3-$16$16
Change in WC$70-$37-$404$172
Other Non-Cash$1,004$22$1,176-$50
Operating Cash Flow-$46-$435-$890-$305
Investing Activities
PP&E Inv.-$9$0-$128-$242
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$13$2$64-$118
Investing Cash Flow-$22$2-$64-$242
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$1,694$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$8$43$1,596$95
Financing Cash Flow$8$43$1,596$190
Forex Effect-$24$11$10-$4
Net Chg. in Cash-$326$0$598-$364
Supplemental Information
Beg. Cash$326$0$107$471
End Cash$0$0$705$107
Free Cash Flow-$55-$435-$1,018-$547